Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Mar 21;22(6):1108–1116. doi: 10.1016/j.bbmt.2016.02.018

Figure 2.

Figure 2

Figure 2

Figure 2

Figure 2

Figure 2

Figure 2

Skeletal pain and body symptoms by donation of peripheral blood stem cells (PBSC) or bone marrow. (A) Skeletal pain experienced by all donors by product at baseline and post-donation. (B) Skeletal pain of domestic donors by product at baseline, peri-collection and post-donation. (C) Highest toxicity level across all body symptoms experienced by all donors by product at baseline and post-donation. (D) Highest toxicity level across all body symptoms by domestic donors by product at baseline, peri-collection, and post-donation. (E) Fatigue of all donors product at baseline and post-donation. (F) Fatigue by domestic donors by product at baseline, peri-collection, and post-donation. Peri-collection time points are day 5 of filgrastim administration for PBSC donors and day 2 following BM collection.